Home/Filings/4/0001062993-25-004352
4//SEC Filing

Ramachandran Niro Ph.D 4

Accession 0001062993-25-004352

CIK 0001711933other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 5:02 PM ET

Size

6.5 KB

Accession

0001062993-25-004352

Insider Transaction Report

Form 4
Period: 2025-03-01
Ramachandran Niro Ph.D
Chief Business Officer
Transactions
  • Tax Payment

    Common Stock

    2025-03-01$1.63/sh2,310$3,765293,114 total
  • Tax Payment

    Common Stock

    2025-03-01$1.63/sh3,594$5,858289,520 total
Footnotes (2)
  • [F1]Represents shares withheld to cover taxes on a restricted stock unit award previously granted on February 23, 2023, which vests in four (4) annual equal installments beginning on March 1, 2024 and annually thereafter until fully vested.
  • [F2]Represents shares withheld to cover taxes on a restricted stock unit award previously granted on February 22, 2024, which vests in four (4) annual equal installments beginning on March 1, 2025 and annually thereafter until fully vested.

Issuer

Akoya Biosciences, Inc.

CIK 0001711933

Entity typeother

Related Parties

1
  • filerCIK 0001857443

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:02 PM ET
Size
6.5 KB